Endocyte, Inc. (ECYT) Reports Q2 Loss of $0.15

Endocyte, Inc. (NASDAQ: ECYT) reported Q2 EPS of ($0.15), versus $0.35 reported last year. Revenue for the quarter came in at $7.8 million versus the consensus estimate of $0 .

For earnings history and earnings-related data on Endocyte, Inc. (ECYT) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Azitra, Inc. (AZTR) Tops Q2 EPS by 54c
• Jefferies upgrades Five Below to Buy, sees path to TJX-like re-rating